PTPRC and melanoma: Defining CTCs in epithelial cancer patients as CD45- CK+ and/or EpCAM+, the detection rate increased to 73% (61/84), and the median count of these cells was 8 (range: 1-105)/10 mL blood, which did not significantly differ anymore from the median count of melanoma cells (p = 0.418).